Scott Dodds

Array ( [id] => 232796 [patent_doc_number] => 07598221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Synthetic HLA binding WT-1 peptide analogues and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/223139 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 10926 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598221.pdf [firstpage_image] =>[orig_patent_app_number] => 11223139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 847212 [patent_doc_number] => 07384912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Treatment of bone disorders with skeletal anabolic drugs' [patent_app_type] => utility [patent_app_number] => 11/216511 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 31262 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384912.pdf [firstpage_image] =>[orig_patent_app_number] => 11216511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916193 [patent_doc_number] => 20080096794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton' [patent_app_type] => utility [patent_app_number] => 11/660595 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4625 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096794.pdf [firstpage_image] =>[orig_patent_app_number] => 11660595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853102 [patent_doc_number] => 20080318845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Selective Vpac2 Receptor Peptide Agonists' [patent_app_type] => utility [patent_app_number] => 11/573903 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21934 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318845.pdf [firstpage_image] =>[orig_patent_app_number] => 11573903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910376 [patent_doc_number] => 07329650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases' [patent_app_type] => utility [patent_app_number] => 11/184459 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 10220 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329650.pdf [firstpage_image] =>[orig_patent_app_number] => 11184459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820034 [patent_doc_number] => 20060024347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Bioactive peptide coatings' [patent_app_type] => utility [patent_app_number] => 11/167636 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19672 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024347.pdf [firstpage_image] =>[orig_patent_app_number] => 11167636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849182 [patent_doc_number] => 07381700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Methods for treating pain associated with arthritis' [patent_app_type] => utility [patent_app_number] => 11/159569 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4276 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381700.pdf [firstpage_image] =>[orig_patent_app_number] => 11159569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244915 [patent_doc_number] => 08202841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'SSX-2 peptide analogs' [patent_app_type] => utility [patent_app_number] => 11/156253 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 36036 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 473 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202841.pdf [firstpage_image] =>[orig_patent_app_number] => 11156253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808306 [patent_doc_number] => 20060094661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'NY-ESO-1 peptide analogs' [patent_app_type] => utility [patent_app_number] => 11/155929 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 35534 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094661.pdf [firstpage_image] =>[orig_patent_app_number] => 11155929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33387 [patent_doc_number] => 07786072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Stabilized compounds having secondary structure motifs' [patent_app_type] => utility [patent_app_number] => 11/148976 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10528 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786072.pdf [firstpage_image] =>[orig_patent_app_number] => 11148976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019987 [patent_doc_number] => 20050222006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Aggregates of human insulin derivatives' [patent_app_type] => utility [patent_app_number] => 11/131996 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5411 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222006.pdf [firstpage_image] =>[orig_patent_app_number] => 11131996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111675 [patent_doc_number] => 20050209131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Composition containing peptides complexed with a copper ion' [patent_app_type] => utility [patent_app_number] => 11/130336 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4422 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209131.pdf [firstpage_image] =>[orig_patent_app_number] => 11130336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111984 [patent_doc_number] => 20050209440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Solid phase native chemical ligation of unprotected or N-terminal Cysteine protected peptides in aqueous solution' [patent_app_type] => utility [patent_app_number] => 11/119831 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15789 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209440.pdf [firstpage_image] =>[orig_patent_app_number] => 11119831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7187662 [patent_doc_number] => 20050192214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Cyclosporine analogue mixtures and their use as immunomodulating agents' [patent_app_type] => utility [patent_app_number] => 11/118830 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25035 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192214.pdf [firstpage_image] =>[orig_patent_app_number] => 11118830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959230 [patent_doc_number] => 20050215484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Di-, tri-, and tetra-peptides having antiangiogenic activity' [patent_app_type] => utility [patent_app_number] => 11/114865 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12751 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215484.pdf [firstpage_image] =>[orig_patent_app_number] => 11114865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944329 [patent_doc_number] => 20050196378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'G-CSF conjugates' [patent_app_type] => utility [patent_app_number] => 11/114576 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7134 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196378.pdf [firstpage_image] =>[orig_patent_app_number] => 11114576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7223869 [patent_doc_number] => 20050261196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Myosin light chain kinase inhibitors and methods of use' [patent_app_type] => utility [patent_app_number] => 11/111463 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12093 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261196.pdf [firstpage_image] =>[orig_patent_app_number] => 11111463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912870 [patent_doc_number] => 20050176628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Deuterated cyclosporin analogs and their use as immunomodulating agents' [patent_app_type] => utility [patent_app_number] => 11/105897 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10687 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176628.pdf [firstpage_image] =>[orig_patent_app_number] => 11105897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672947 [patent_doc_number] => 20060178302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Amyloid beta protein (globular assembly and uses thereof)' [patent_app_type] => utility [patent_app_number] => 11/100212 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22767 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178302.pdf [firstpage_image] =>[orig_patent_app_number] => 11100212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141891 [patent_doc_number] => 07687455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Antigen delivery vectors and constructs' [patent_app_type] => utility [patent_app_number] => 11/096725 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 8294 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687455.pdf [firstpage_image] =>[orig_patent_app_number] => 11096725 [rel_patent_id] =>[rel_patent_doc_number] =>)